Phase I study of A166, an antibody‒drug conjugate in advanced HER2-expressing solid tumours.

Autor: Zhang, Jian, Liu, Rujiao, Gao, Shuiping, Li, Wenhua, Chen, Yang, Meng, Yanchun, Liu, Chang, Jin, Wenyue, Wu, Junyan, Wang, Ying, Hao, Yanrong, Yi, Shuli, Qing, Yan, Ge, Junyou, Hu, Xichun
Zdroj: NPJ Breast Cancer; 4/18/2023, Vol. 9 Issue 1, p1-7, 7p
Databáze: Complementary Index
Externí odkaz: